A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Research progress of antibiotics in the treatment of meibomian gland dysfunction
2022
Guoji Yanke Zazhi
Meibomian gland dysfunction(MGD)is a chronic, diffuse blepharoplasty that is characterized by obstruction of the terminal ducts of the blepharoplasty gland and abnormal lid ester secretion, which is a common ocular surface disease as well as the major cause of hyper evaporation type dry eye. MGD can cause ocular surface lid ester abnormalities and bacterial proliferation, which in turn leads to associated ocular symptoms. Physical therapies and medicines are widely used to treat MGD in clinics.
doi:10.3980/j.issn.1672-5123.2022.5.26
doaj:67a288df753541ffb0e16f75f585de30
fatcat:bqg3r7hqybb4ral2nxcq4336tq